Join us for a quick tour around ch-aviation with an introduction to its Commercial Aviation data & news and best practices ...
ImmuPharm PLC (IMM.L), a clinical-stage specialty drug company, on Tuesday reported interim financial results for the six months ending June 30, 2026. Loss for the half-year period widened due to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results